CMS Sees No "Systemic" Problems From Cancer Rx Payment Cuts
This article was originally published in The Pink Sheet Daily
Executive Summary
Incoming Centers for Medicare & Medicaid Services Administrator McClellan says the agency will "closely" monitor whether beneficiary access is impacted by reimbursement changes for Part B drugs.